NEXTCURE INC

Nextcure Inc. (NXTC) dips 0.46% but has up 4.54% monthly; market cap $24.9M, 200‑day SMA $8.12. Discover the latest stock update and clinical‑stage focus.

Nextcure (NXTC) drops 4.06% as investors eye upcoming clinical milestones and a 200‑day SMA of $8.16, amid moderate liquidity and peer volatility.

Nextcure (NXTC) stock dips 9.1% to $5.44, trading 4.6M shares with a $28.6M market cap. Discover the latest price, trends, and key metrics for investors.